H.B. Fuller Company
NYSE:FULChemicals - Specialty
-$0.09 today
- Market cap
- $2.59B
- Beta
- 0.96
- P/E (TTM)
- 22.2
- EPS (TTM)
- $2.92
- Dividend yield
- 1.47%
Volume 0.34M
Average 0.66M
FUL Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
H.B. Fuller CompanyNYSE: FUL
Revenue · Q3 FY2026 · quarter ended Aug 2026
Revenue growth accelerates
Q3 FY2026 revenue of $938.18M rose 5.2% year over year, ahead of the +1.5% change in trailing-twelve-month revenue. Sequentially, it fell 1.3% from the prior quarter. Over 3 fiscal years it compounded at -2.5% a year.
Context
- Revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $3.61B (+3.8%) for the fiscal year ending Nov 2026, a step up from the -2.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterAug 2026
- $938.18M-1.3% QoQ
- Last fiscal yearNov 2025
- $3.47B-2.7% YoY
- LTMAug 2026
- $3.55B+1.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.2% | +5.7% | +0.6 pp |
| 1 year | -2.7% | +3.8% | +6.5 pp |
| 3-year CAGR | -2.5% | +4.8% | +7.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 3.47B USD
- Year-over-year change
- -2.7%
- 4-year CAGR
- +1.5%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-29 | 3.47B | -2.7% |
| FY2024 | 2024-11-30 | 3.57B | +1.6% |
| FY2023 | 2023-12-02 | 3.51B | -6.4% |
| FY2022 | 2022-12-03 | 3.75B | +14.4% |
| FY2021 | 2021-11-27 | 3.28B | — |
Revenue vs competitors
How FUL compares with its peers on the latest reported figures
- FUL's LTM Aug 2026 revenue of $3.55B is the 3rd highest of the 11 companies compared; the peer median is $2.35B.
- Its year-over-year change of +1.5% is the 8th highest of 11, against a peer median of +6.7%.
- Over three fiscal years its annual growth of -2.5% compares with a peer median of +1.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $6.7B | +0.6% | -10.2% | |
| LTM Jun 2026 | $3.63B | -4.7% | -4.9% | |
| LTM Aug 2026 | $3.55B | +1.5% | -2.5% | |
| LTM Sep 2026 | $3.42B | +5.2% | -1.4% | |
| LTM Jun 2026 | $3.37B | -2.0% | -4.5% | |
| LTM Sep 2026 | $3B | +18.7% | -3.1% | |
| LTM Jun 2026 | $1.7B | +8.1% | +3.9% | |
| LTM Sep 2026 | $1.14B | +9.0% | +5.0% | |
| LTM Jun 2026 | $757.07M | +24.2% | +21.9% | |
| LTM Aug 2026 | $687.99M | +11.0% | +8.6% | |
| LTM Sep 2026 | $381.09M | +4.5% | +16.4% | |
| Peer median (excluding FUL) | $2.35B | +6.7% | +1.3% | |
Competitors are the stored peer set for FUL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Nov 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 3.28B | 3.75B | 3.51B | 3.57B | 3.47B |
| Cost of Revenue | 2.43B | 2.79B | 2.49B | 2.49B | 2.37B |
| Gross Profit | 845.13M | 963.55M | 1.02B | 1.07B | 1.1B |
| Gross Margin | 25.8% | 25.7% | 29.2% | 30.1% | 31.7% |
| Research & Development | 39.34M | 44.85M | 48.64M | 49.57M | 0 |
| Selling, General & Admin | 550.09M | 596.4M | 595.78M | 655.64M | 701.73M |
| Operating Expenses | 589.44M | 641.26M | 644.42M | 705.2M | 701.73M |
| Depreciation & Amortization | 143.17M | 146.98M | 159.84M | 174.71M | 178.32M |
| EBITDA | 438.12M | 490.43M | 528.6M | 490.5M | 527.08M |
| EBITDA Margin | 13.4% | 13.1% | 15.1% | 13.7% | 15.2% |
| Operating Income | 255.7M | 322.29M | 379.49M | 368.94M | 399.12M |
| Operating Margin | 7.8% | 8.6% | 10.8% | 10.3% | 11.5% |
| Interest Income | 9.48M | 7.78M | 3.94M | 4.68M | 4.82M |
| Interest Expense | 78.09M | 91.52M | 134.6M | 133.12M | 133.35M |
| Other Income / Expenses | (31.19M) | (64.7M) | (140.97M) | (182.16M) | (179.92M) |
| Income Before Tax | 224.51M | 257.59M | 238.52M | 186.78M | 219.2M |
| Pre-Tax Margin | 6.8% | 6.9% | 6.8% | 5.2% | 6.3% |
| Income Tax Expense | 63.03M | 77.19M | 93.53M | 56.38M | 67.13M |
| Net Income | 161.39M | 180.31M | 144.91M | 130.26M | 151.97M |
| Net Margin | 4.9% | 4.8% | 4.1% | 3.6% | 4.4% |
| EPS (Basic) | 3.05 | 3.37 | 2.67 | 2.37 | 2.78 |
| EPS (Diluted) | 2.97 | 3.26 | 2.59 | 2.30 | 2.75 |
| Weighted Avg Shares | 52.89M | 53.58M | 54.33M | 54.93M | 54.6M |
| Weighted Avg Shares (Diluted) | 54.32M | 55.27M | 55.96M | 56.63M | 55.36M |
H.B. Fuller Company
NYSE:FUL
Intrinsic Alpha fair value
Locked
Current Price
$48.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.